GrewalDSLeungEBusquetsM, et al. Bevacizumab first in DRCR Protocol AC vs real-world physician treatment choice for diabetic macular edema: two-year cost analysis. J Vitreoretin Dis. 2024;8(6):658-663.
2.
KhodorAChoiSNandaT, et al. Visual and anatomic responses in patients with neovascular age-related macular degeneration and a suboptimal response to anti-VEGF therapy switched to faricimab. J Vitreoretin Dis. 2024;8(6):643-650.
3.
ThomsonKBKhalidSISabherwalNHeifermanMJ.Association between tobacco smoking and the development of diabetic macular edema. J Vitreoretin Dis. 2024;8(6):651-657.
4.
JustinGAWinslowLKunduA, et al. Macular, choroidal, and peripapillary perfusion changes in mild and moderate traumatic brain injury using optical coherence tomography and angiography. J Vitreoretin Dis. 2024;8(6):664-674.
5.
ShahlaeeAIsrailevichRNMahmoudzadehR, et al. Outcomes of rhegmatogenous retinal detachment repair in pseudophakic eyes with multifocal vs monofocal intraocular lenses. J Vitreoretin Dis. 2024;8(6):675-680.
6.
JiaoGShahPPShakinEP, et al. Ophthalmic outcomes after silicone oil removal. J Vitreoretin Dis. 2024;8(6):681-686.
7.
KannanNBSayyadKJVallinayagamMK, et al. Anatomic and visual outcomes of scleral buckle in primary rhegmatogenous retinal detachment in the era of pars plana vitrectomy. J Vitreoretin Dis. 2024;8(6):687-693.
8.
LohGKMishraAVSeamoneMTennantM.Unified approach to treating exogenous endophthalmitis with immediate vitrectomy. J Vitreoretin Dis. 2024;8(6):694-698.
9.
RahmanSTayyabHSiddiquiMAR. Suprachoroidal triamcinolone acetonide injection to treat macular edema: a review. J Vitreoretin Dis. 2024;8(6):699-708.
10.
StaurenghiGSouiedEHIidaT, et al. Imaging-guided classification of neovascularization in neovascular age-related macular degeneration: progress to date. J Vitreoretin Dis. 2024;8(6):709-718.
11.
AkdumanLOzdekSErmisSOzdemir-ZeydanliEArtunayOAbou ShoushaM.Myopia support device (titanium macular buckle) for posterior pole retinal detachment with or without myopic maculoschisis. J Vitreoretin Dis. 2024;8(6):719-724.
12.
TsaiASHKaufmanARChanRVP. Serial OCT imaging of spontaneous closure of a pediatric traumatic macular hole. J Vitreoretin Dis. 2024;8(6):725-727.
13.
PrairieMLRubinoSMTangPH.Resolution of lipemia retinalis with lifestyle modification. J Vitreoretin Dis. 2024;8(6):728-730.
14.
BloomJMadaniRHaidarAJAlasilT.Faricimab treatment of polypoidal choroidal vasculopathy resistant to intravitreal ranibizumab injections and ranibizumab port delivery (Susvimo). J Vitreoretin Dis. 2024;8(6):731-734.
15.
GhiamSPirouzAAdreanSD.Potential new phenotypic presentation of pentosan polysulfate sodium maculopathy. J Vitreoretin Dis. 2024;8(6):735-739.
DiraniKAlfaroCAl-TimimiFRJuzychDYoganathanP.Retinal toxicity secondary to suprachoroidal migration of mitomycin-C. J Vitreoretin Dis. 2024;8(6):744-748.
18.
KozekLKMorcosDHoyekSPatelNA.Choriocapillaris loss in a pediatric patient with congenital cytomegalovirus seen on optical coherence tomography angiography. J Vitreoretin Dis. 2024;8(6):749-752.
19.
OzkardesCSandersRNBrooksHLShakarchiA.Macular edema causing spontaneous closure of a macular hole after unsuccessful primary surgical repair. J Vitreoretin Dis. 2024;8(6):753-757.
20.
TakharJSMehraAAKurupSK, et al. Resolution of anterior uveal infiltration of acute lymphoblastic leukemia after chimeric antigen receptor T-cell therapy. J Vitreoretin Dis. 2024;8(6):758-762.
